Universal American ACOs and Fresenius Medical Care Partner to Improve Health of End Stage Renal Disease Patients

Go back to Universal American ACOs and Fresenius Medical Care Partner to Improve Health of End Stage Renal Disease Patients

Fresenius Medical Care (FMS) Tops Q3 EPS Views

October 27, 2016 9:06 AM EDT

Fresenius Medical Care (NYSE: FMS) reported Q3 EPS of $1.09, $0.57 better than the analyst estimate of $0.52. Revenue for the quarter came in at $4.6 billion versus the consensus estimate of $4.55 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

... More